Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

178.52 -0.21 (-0.12%)

Streaming Delayed Price Updated: 12:41 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids

August 16, 2021

From Masimo

Via Business Wire

Masimo (MASI) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

MASI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Masimo: Q2 Earnings Insights ↗

July 27, 2021

Shares of Masimo (NASDAQ:MASI) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 10.59% year over year to $...

Via Benzinga

Masimo Reports Second Quarter 2021 Financial Results

July 27, 2021

From Masimo

Via Business Wire

Earnings Scheduled For July 27, 2021 ↗

July 27, 2021

Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

Masimo Earnings Preview ↗

July 26, 2021

On Tuesday, July 27, Masimo (NASDAQ:MASI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings Per...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing Partners

July 19, 2021

From Masimo

Via Business Wire

Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27

July 13, 2021

From Masimo

Via Business Wire

New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients

July 06, 2021

From Masimo

Via Business Wire

Masimo's Wearable Thermometer Scores FDA Approval For Prescription, OTC Use ↗

June 21, 2021

Masimo (NASDAQ: MASI) has announced that Radius Tº, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-...

Via Benzinga

Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) Use

June 21, 2021

From Masimo

Via Business Wire

Inflation Fears and Stock Market News ↗

June 20, 2021

Plus, best-selling author Daniel Kahneman shares insights from his new book, "Noise: A Flaw in Human Judgment."

Via The Motley Fool

New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation

June 14, 2021

From Masimo

Via Business Wire

Masimo to Present in UBS Global Healthcare Virtual Conference

May 19, 2021

From Masimo

Via Business Wire

New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward

May 17, 2021

From Masimo

Via Business Wire

Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality

May 10, 2021

From Masimo

Via Business Wire

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

May 03, 2021

From Masimo

Via Business Wire

Masimo (MASI) Q1 2021 Earnings Call Transcript ↗

April 26, 2021

MASI earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Masimo: Q1 Earnings Insights ↗

April 26, 2021

Shares of Masimo (NASDAQ:MASI) remain flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 7.22% year over year to $0...

Via Benzinga

Masimo Reports First Quarter 2021 Financial Results

April 26, 2021

From Masimo

Via Business Wire

Earnings Scheduled For April 26, 2021 ↗

April 26, 2021

Companies Reporting Before The Bell • Albertsons Companies (NYSE:ACI) is projected to report quarterly earnings at $0.51 per share on revenue of $15.63 billion....

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Corporate America Helped Pour $61M Into Biden Inaugural Committee: Here Are The Companies That Donated ↗

April 21, 2021

The old saying that politics makes strange bedfellows was reaffirmed this year as the nation’s major corporations generously donated to the inaugural committee of the...

Via Benzinga

Masimo Reschedules Date of First Quarter 2021 Financial Results Conference Call

April 19, 2021

From Masimo

Via Business Wire

Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27

April 14, 2021

From Masimo

Via Business Wire

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

April 12, 2021

From Masimo

Via Business Wire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.